Literature DB >> 12457608

Lymphocyte commitment during embryonic development, in the mouse.

Iyadh Douagi1, Paulo Vieira, Ana Cumano.   

Abstract

Multipotent hematopoietic stem cells (HSC) differentiate into mature cells in the fetal liver (FL) during embryonic development, and in the bone marrow (BM) in adult animals. Multilineage differentiation is accomplished by the stepwise commitment of stem cells that sequentially loose differentiation potential. The characterization of the intermediate lymphoid precursors isolated from both hematopoietic sites suggests that, in FL, their potential of differentiation as well as their growth factor requirements are apparently less strict than in the BM. This could be the result of different commitment strategies at those sites: stochastic in the FL and instructive in the BM.

Entities:  

Mesh：

Year:  2002        PMID： 12457608     DOI： 10.1016/s1044532302000702

Source DB:  PubMed          Journal:  Semin Immunol        ISSN： 1044-5323            Impact factor:   11.130


  10 in total

1.  Fell Pony syndrome: characterization of developmental hematopoiesis failure and associated gene expression profiles.

Authors:  Rebecca L Tallmadge; Tracy Stokol; Mary Jean Gould-Earley; Ed Earley; Erica J Secor; Mary Beth Matychak; M Julia B Felippe
Journal:  Clin Vaccine Immunol       Date:  2012-05-16

2.  Propensity of adult lymphoid progenitors to progress to DN2/3 stage thymocytes with Notch receptor ligation.

Authors:  Jiaxue Huang; Karla P Garrett; Rosana Pelayo; Juan Carlos Zúñiga-Pflücker; Howard T Petrie; Paul W Kincade
Journal:  J Immunol       Date:  2005-10-15       Impact factor: 5.422

3.  Two waves of distinct hematopoietic progenitor cells colonize the fetal thymus.

Authors:  Cyrille Ramond; Claire Berthault; Odile Burlen-Defranoux; Ana Pereira de Sousa; Delphine Guy-Grand; Paulo Vieira; Pablo Pereira; Ana Cumano
Journal:  Nat Immunol       Date:  2013-12-08       Impact factor: 25.606

4.  An evolutionarily conserved program of B-cell development and activation in zebrafish.

Authors:  Dawne M Page; Valerie Wittamer; Julien Y Bertrand; Kanako L Lewis; David N Pratt; Noemi Delgado; Sarah E Schale; Caitlyn McGue; Bradley H Jacobsen; Alyssa Doty; Yvonne Pao; Hongbo Yang; Neil C Chi; Brad G Magor; David Traver
Journal:  Blood       Date:  2013-07-16       Impact factor: 22.113

5.  In vitro differentiation of adult bone marrow progenitors into antigen-specific CD4 helper T cells using engineered stromal cells expressing a notch ligand and a major histocompatibility complex class II protein.

Authors:  Bingbing Dai; Pin Wang
Journal:  Stem Cells Dev       Date:  2009-03       Impact factor: 3.272

Review 6.  Stem cells and aging in the hematopoietic system.

Authors:  Luigi A Warren; Derrick J Rossi
Journal:  Mech Ageing Dev       Date:  2008-04-08       Impact factor: 5.432

7.  Characterization of the thymic IL-7 niche in vivo.

Authors:  Nuno L Alves; Odile Richard-Le Goff; Nicholas D Huntington; Ana Patricia Sousa; Vera S G Ribeiro; Allison Bordack; Francina Langa Vives; Lucie Peduto; Ann Chidgey; Ana Cumano; Richard Boyd; Gerard Eberl; James P Di Santo
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-21       Impact factor: 11.205

8.  Interleukin-7 is necessary to maintain the B cell potential in common lymphoid progenitors.

Authors:  Sheila Dias; Hamilton Silva; Ana Cumano; Paulo Vieira
Journal:  J Exp Med       Date:  2005-03-14       Impact factor: 14.307

9.  Thymic B cell development is controlled by the B potential of progenitors via both hematopoietic-intrinsic and thymic microenvironment-intrinsic regulatory mechanisms.

Authors:  Shiyun Xiao; Wen Zhang; Nancy R Manley
Journal:  PLoS One       Date:  2018-02-20       Impact factor: 3.240

Review 10.  Relevance of the Materno-Fetal Interface for the Induction of Antigen-Specific Immune Tolerance.

Authors:  Angelina Mimoun; Sandrine Delignat; Ivan Peyron; Victoria Daventure; Maxime Lecerf; Jordan D Dimitrov; Srinivas V Kaveri; Jagadeesh Bayry; Sébastien Lacroix-Desmazes
Journal:  Front Immunol       Date:  2020-05-14       Impact factor: 7.561
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.